SECUKINUMAB

Secukinumab 300 mg/2 mL injection, 2 mL pen device

SECUKINUMAB (14971Y)

Secukinumab 300 mg/2 mL injection, 2 mL pen device
14971Y
Body System:
Manner of administration:Injection
General Schedule
Authority Required

Restriction

Indication: Severe chronic plaque psoriasis
Treatment phase: Initial 1, Whole body or Face, hand, foot (new patient) or Initial 2, Whole body or Face, hand, foot (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3, Whole body or Face, hand, foot (re-commencement of treatment after a break in biological medicine of more than 5 years) - balance of supply
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 2 DPMQ: $1,336.27 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Cosentyx